Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates
- PMID: 1567898
- DOI: 10.1016/0005-2736(92)90165-i
Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates
Abstract
Transplasma membrane electron transport from HeLa cells, measured by reduction of ferricyanide or diferric transferrin in the presence of bathophenanthroline disulfonate, is inhibited by low concentrations of adriamycin and adriamycin conjugated to diferric transferrin. Inhibition with the conjugate is observed at one-tenth the concentration required for adriamycin inhibition. The inhibitory action of the conjugate appears to be at the plasma membrane since (a) the conjugate does not transfer adriamycin to the nucleus, (b) the inhibition is observed within three minutes of addition to cells, and (c) the inhibition is observed with NADH dehydrogenase and oxidase activities of isolated plasma membranes. Cytostatic effects of the compounds on HeLa cells show the same concentration dependence as for enzyme inhibition. The adriamycin-ferric transferrin conjugate provides a more effective tool for inhibition of the plasma membrane electron transport than is given by the free drug.
Similar articles
-
Diferric transferrin reductase in the plasma membrane is inhibited by adriamycin.Biochem Int. 1987 Jan;14(1):119-27. Biochem Int. 1987. PMID: 3566771
-
Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells.Biochem Int. 1991 Dec;25(5):815-22. Biochem Int. 1991. PMID: 1666508
-
Transplasma membrane electron and proton transport is inhibited by chloroquine.Biochem Int. 1990;21(4):761-9. Biochem Int. 1990. PMID: 2173587
-
Coenzyme Q10, plasma membrane oxidase and growth control.Mol Aspects Med. 1994;15 Suppl:s1-11. doi: 10.1016/0098-2997(94)90008-6. Mol Aspects Med. 1994. PMID: 7752819 Review.
-
High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases.Antioxid Redox Signal. 2000 Summer;2(2):231-42. doi: 10.1089/ars.2000.2.2-231. Antioxid Redox Signal. 2000. PMID: 11229528 Review.
Cited by
-
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.J Membr Biol. 2014 Apr;247(4):291-307. doi: 10.1007/s00232-014-9637-0. Epub 2014 Feb 27. J Membr Biol. 2014. PMID: 24573305 Review.
-
Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?J Bioenerg Biomembr. 1997 Jun;29(3):269-80. doi: 10.1023/a:1022414228013. J Bioenerg Biomembr. 1997. PMID: 9298712
-
Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.Cell Mol Biol Lett. 2009;14(1):113-27. doi: 10.2478/s11658-008-0037-2. Epub 2008 Oct 10. Cell Mol Biol Lett. 2009. PMID: 18850074 Free PMC article.
-
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Biochim Biophys Acta. 2012 Mar;1820(3):291-317. doi: 10.1016/j.bbagen.2011.07.016. Epub 2011 Aug 5. Biochim Biophys Acta. 2012. PMID: 21851850 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources